| Joel B Dashut, DDS | |
|
4358 W Cheyenne Ave, N Las Vegas, NV 89032-2484 | |
| (702) 735-9500 | |
| (702) 693-6500 |
| Full Name | Joel B Dashut |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 4358 W Cheyenne Ave, N Las Vegas, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407872245 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 3327 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joel B Dashut, DDS 941 Granger Farm Way, Las Vegas, NV 89145-8619 Ph: (702) 696-0866 | Joel B Dashut, DDS 4358 W Cheyenne Ave, N Las Vegas, NV 89032-2484 Ph: (702) 735-9500 |
News Archive
Portola Pharmaceuticals, Inc. today announced that it has initiated its first in human Phase 1 trial in healthy volunteers of PRT062607, a novel, oral Syk-specific kinase inhibitor in development to treat chronic inflammatory diseases, including rheumatoid arthritis (RA), and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. In preclinical in vivo models of RA, PRT062607 was shown to reduce inflammation in a dose-dependent manner.
Different kinds of lung cancer behave in different ways, suggesting they are fundamentally different diseases. According to a University of Colorado Cancer Center study published in Cancer, the official journal of the American Cancer Society, different subgroups of non-small cell lung cancer (NSCLC) show distinct patterns of spread in the body.
Human Genome Sciences has announced a license agreement with Amgen under which Amgen has acquired exclusive worldwide rights to develop and commercialize therapeutic biological products for human use based on a human gene discovered by Human Genome Sciences that may have potential applications in autoimmune diseases, immune deficiencies or suppression, and cancer.
Genzyme Corp. has signed a consent decree agreeing to correct manufacturing quality violations at its Allston, Mass., manufacturing facility and will turn over to the federal government $175 million in unlawful profits from the sale of products that were made at the plant, the U.S. Food and Drug Administration announced today.
› Verified 7 days ago
Dr. Heddamarie U.t. Hart, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 8225 Sawmill Falls St, N Las Vegas, NV 89085 Phone: 702-304-8300 Fax: 702-304-8300 | |
Catherine Ariel Canda, Dentist Medicare: Not Enrolled in Medicare Practice Location: 6821 Arcadia Creek St, N Las Vegas, NV 89084 Phone: 702-379-3289 | |
Dr. Ji In Kim, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 150 E Centennial Pkwy Ste 113, N Las Vegas, NV 89084 Phone: 702-642-1386 Fax: 702-642-6321 | |
Mr. Lance J Kim, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, N Las Vegas, NV 89086 Phone: 702-791-9000 Fax: 702-642-6321 | |
Huy Cao Nguyen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 78 Broken Putter Way, N Las Vegas, NV 89148 Phone: 702-371-8567 Fax: 702-685-8867 | |
Randy Hong, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 5465 Simmons St Ste 4, N Las Vegas, NV 89031 Phone: 702-638-1005 Fax: 702-638-1071 |